Mesoblast share price crashes 29% lower on FDA doubts – Motley Fool Australia

The Mesoblast limited(ASX: MSB) share price has been the worst performer on the S&P/ASX 200 Index (ASX: XJO) by some distance on Tuesday.
In afternoon trade the biotechnology company’s shares are down 26% to $3.62.
At one stage, the Mesoblast share price was down as much as 29% to $3.46.
Why is the Mesoblast share price crashing lower?
Investors have been hitting the sell button in a panic on Tuesday after the U.S. Food and Drug Administration (FDA) released a briefing document ahead of …

Click here to view the original article.